Mitochondrial tumour suppressors: a genetic and biochemical update
about
A recurrent stop-codon mutation in succinate dehydrogenase subunit B gene in normal peripheral blood and childhood T-cell acute leukemiaFumarase: a mitochondrial metabolic enzyme and a cytosolic/nuclear component of the DNA damage responsePyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cellsmiR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activityLithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cellsStable isotope-resolved metabolomics and applications for drug developmentState of the science: an update on renal cell carcinomaRedox-directed cancer therapeutics: molecular mechanisms and opportunitiesPolymorphisms in mitochondrial genes and prostate cancer riskCell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cellsFundamentals of cancer metabolismMitochondrial metabolic remodeling in response to genetic and environmental perturbationsHepatocellular carcinoma: Review of disease and tumor biomarkersA novel approach to the discovery of anti-tumor pharmaceuticals: searching for activators of liponecrosisDysregulated metabolism contributes to oncogenesisCancer metabolism: key players in metabolic reprogrammingHypoxamiRs and cancer: from biology to targeted therapyNovel therapeutic targets of tumor metabolismSurvivin promotes oxidative phosphorylation, subcellular mitochondrial repositioning, and tumor cell invasionIDH mutations in tumorigenesis and their potential role as novel therapeutic targets.Mitochondrial disease: powerhouse of diseaseStructure-based development of small molecule PFKFB3 inhibitors: a framework for potential cancer therapeutic agents targeting the Warburg effectTumour suppressor Fus1 provides a molecular link between inflammatory response and mitochondrial homeostasisDual mode action of mangiferin in mouse liver under high fat dietMitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicityMultiscale models of angiogenesisAngiostatin regulates the expression of antiangiogenic and proapoptotic pathways via targeted inhibition of mitochondrial proteinsA neuronal network of mitochondrial dynamics regulates metastasis.Analysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma.Cytoplasmic signaling in the control of mitochondrial uproar?The genomic analysis of lactic acidosis and acidosis response in human cancersThe first Dutch SDHB founder deletion in paraganglioma-pheochromocytoma patientsNo evidence for promoter region methylation of the succinate dehydrogenase and fumarate hydratase tumour suppressor genes in breast cancer.Immunohistochemical expression of mitochondrial membrane complexes (MMCs) I, III, IV and V in malignant and benign periampullary epithelium: a potential target for drug therapy of periampullary cancer?Succinate-to-fumarate ratio as a new metabolic marker to detect the presence of SDHB/D-related paraganglioma: initial experimental and ex vivo findings.Current views on cell metabolism in SDHx-related pheochromocytoma and paragangliomaElevated plasma succinate in PTEN, SDHB, and SDHD mutation-positive individuals.Multiplex analysis of mitochondrial DNA pathogenic and polymorphic sequence variants.Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis.Paragangliomas/Pheochromocytomas: clinically oriented genetic testing
P2860
Q21092253-8C2FA745-09C2-4FDD-9209-C233F38E82E5Q21145799-8C714067-9F58-4907-8A1D-587DBDE4E0BDQ24320179-6F6E31EE-218B-4027-92A4-0EB247848969Q24595376-E208F73C-8FBF-4218-A48F-FF9123E2BAE6Q24617423-335741FB-B3C1-4BC6-A927-85FFDFD3A1F8Q24629149-122FD527-8F65-49BA-B378-0D172B49C98FQ24630685-0B0725FF-B00C-41E1-A88A-CD4C1BD8E540Q24645584-F1B39654-9B50-44BC-AAE4-CCCACD21CFB8Q24647983-695553E6-14B0-43D3-A6CE-496ECDEE748AQ24683296-A0FF1397-2AA6-4158-95AB-04C1B932F0CEQ26744062-9C8C2AAE-55E4-418B-8F61-D6194C765BC8Q26747718-F687CC71-AC3E-4E37-BF2B-0BEF74065C20Q26750796-831190EC-5864-44C6-9D39-723AF10E671BQ26774351-07FD24B2-3FB7-4C65-9F9F-97AAFD336117Q26784630-5196864F-E338-49DF-B00E-338C7B95F5D0Q26827663-7C5B93DB-8C82-4BF1-8A25-A40E7D3E2B46Q26863298-0AD8C75E-AD47-4132-A77A-A29636B1F796Q27005930-357C6D1E-40D1-433A-B590-2CDDA820A46BQ27329571-3891C8F6-8447-48C2-83B6-BC370FF74CCFQ27692015-25E15ED3-D7C0-46C3-99AE-4D3E1A5F5447Q28304409-9A8C4F5B-E363-4BF9-BB03-D7CF1983A151Q28477166-42C18F8E-980B-418E-9436-FCB9C7DB3120Q28507927-CCDC221D-D56C-46F2-83A5-4BBA1C484FE3Q28540472-638709AA-4D52-48E1-82D4-C5F4AA5B7593Q29616651-6400F350-D95D-445B-B4DE-A7A5CDD2E97DQ30432668-9FDC43EF-4E9E-4506-ABF4-80CEBC2D7694Q30490006-0AFC27AB-FFF5-4141-8F03-1BF7BCD998A0Q30833071-F57DFC33-D7C7-44B5-B214-F84CF50C970AQ30928926-2B2C3A3F-9B7E-4FF8-BC7C-5203E781AB58Q33361448-C956B1C1-03A9-42DD-8B05-D3F40D797F41Q33389864-CF6D6B57-61FC-4743-8FE6-48124D4E5E40Q33430491-A8EA8FD8-F2B9-46B7-8E9B-7E080F6E7D5EQ33506548-7908D07C-5B7D-4404-BFB1-AD54F4B30B0CQ33536840-CFA6787F-27B1-4E2F-BCAB-2ECE4EA73995Q33585065-40CF25A9-7CA5-4D24-B1E6-63A72A9BDBE9Q33590969-E581DB75-FBE1-4385-861B-1495A3AC7203Q33606551-B0EA07EB-DA6B-4BEE-A2C5-03FFDF1F01FFQ33622660-6822A973-8F09-481A-A6F5-C967D0259178Q33623036-508EF49A-717C-4B4A-82AF-F7A6BE0B8AECQ33679204-C9F07F7E-4704-4E76-BBAF-0779BA15AAE2
P2860
Mitochondrial tumour suppressors: a genetic and biochemical update
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Mitochondrial tumour suppressors: a genetic and biochemical update
@ast
Mitochondrial tumour suppressors: a genetic and biochemical update
@en
Mitochondrial tumour suppressors: a genetic and biochemical update
@nl
type
label
Mitochondrial tumour suppressors: a genetic and biochemical update
@ast
Mitochondrial tumour suppressors: a genetic and biochemical update
@en
Mitochondrial tumour suppressors: a genetic and biochemical update
@nl
prefLabel
Mitochondrial tumour suppressors: a genetic and biochemical update
@ast
Mitochondrial tumour suppressors: a genetic and biochemical update
@en
Mitochondrial tumour suppressors: a genetic and biochemical update
@nl
P2860
P3181
P356
P1476
Mitochondrial tumour suppressors: a genetic and biochemical update
@en
P2093
Eyal Gottlieb
Ian P M Tomlinson
P2860
P2888
P304
P3181
P356
10.1038/NRC1737
P407
P577
2005-11-01T00:00:00Z
P6179
1049254247